Skip to main content
. 2020 Aug 18;12(2):8652. doi: 10.4081/ni.2020.8652

Table 3.

Clinical and subclinical feature comparison between patients with and without spinal cord lesions.

Features Patients with spinal cord lesion (n = 32) Patients without spinal cord lesion (n = 15) P-value
Duration of using (mean ± SD) (min–max) (months) 13.0 ± 9.3 (2–36) 6.8 ± 4.8 (2–24) 0.01*b
Days of using per week (mean ± SD) (min–max) (days) 3.6 ± 2.2 (2–6) 2.2 ± 1.1 (1–4) < 0.001*b
Balls per day (mean ± SD) (min–max) (balls) 40.0 ± 25.5 (10–100) 28.3 ± 15.5 (10–60) 0.188b
RBC# (mean ± SD) (min–max) (T/L) 4.2 ± 0.6 (3.19–5.72) 4.7 ± 0.7 (3.36–5.75) 0.226b
HGB# (mean ± SD) (min–max) (g/L) 126.6 ± 16.4 (87–158) 137.7 ± 16.3 (108–162) 0.031*b
Homocysteine# (mean ± SD) (min–max) (μmol/L) 46.8 ± 25.4 (5.1–83) 56.0 ± 32.0 (5.89–129) 0.332b
Vitamin B12# (mean ± SD) (min–max) (pmol/mL) 383.12 ± 424.4 (65–1476) 328.27 ± 476.7 (62–1476) 0.451b
Lhermitte sign 20 (62.5%) 1 (6.7%) < 0.001*c
Romberg sign 29 (90.6%) 10 (66.7%) 0.089c
Hyperintense on T2W 32 (100%) 0 < 0.001*c
Hypointense on T1W 10 0 < 0.001*c
“Inverted V” sign 30 (94%) 0 < 0.001*c

#Values at hospital admission.

bP-value was calculated using the Mann-Whitney U test.

cP-value was calculated using Fisher’s exact/chi-squared test.

*Indicates a significant statistical difference as P<0.05. RBC, red blood cells; HGB, hemoglobin; T1W, T1-weighted; T2W, T2-weighted; SD, Standard deviation